检索结果 - Mary Mckenney

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    CLAMP and Zelda function together to promote Drosophila zygotic genome activation

    CLAMP and Zelda function together to promote Drosophila zygotic genome activation 由 Jingyue Duan, Leila E. Rieder, Megan M Colonnetta, Annie Huang, Mary Mckenney, Scott Watters, Girish Deshpande, William T. Jordan, Nicolas L. Fawzi, Erica Larschan

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma

    Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma 由 Paul G. Richardson, Edie Weller, Sundar Jagannath, David Avigan, Melissa Alsina, Robert Schlossman, Amitabha Mazumder, Nikhil C. Munshi, Irene M. Ghobrial, Deborah Doss, Diane Warren, Laura Lunde, Mary McKenney, Carol Delaney, Constantine Mitsiades, Teru Hideshima, William S. Dalton, Robert Knight, Dixie‐Lee Esseltine, Kenneth C. Anderson

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

    Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma 由 Paul G. Richardson, Robert Schlossman, Edie Weller, Teru Hideshima, Constantine S. Mitsiades, Faith E. Davies, Richard LeBlanc, Laurence Catley, Deborah Doss, Kathleen Kelly, Mary McKenney, Julie Mechlowicz, Andrea Freeman, Reggie Deocampo, Rebecca L. Rich, Joan J. Ryoo, Dharminder Chauhan, Kathe Balinski, Jerome B. Zeldis, Kenneth C. Anderson

    出版 2002
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

    A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma 由 Paul G. Richardson, Wanling Xie, Sundar Jagannath, Andrzej Jakubowiak, Sagar Lonial, Noopur Raje, Melissa Alsina, Irene M. Ghobrial, Robert Schlossman, Nikhil C. Munshi, Amitabha Mazumder, David H. Vesole, Jonathan L. Kaufman, Kathleen Colson, Mary McKenney, Laura Lunde, John Feather, Michelle E. Maglio, Diane Warren, Dixil Francis, Teru Hideshima, Robert Knight, Dixie‐Lee Esseltine, Constantine S. Mitsiades, Edie Weller, Kenneth C. Anderson

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

    A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma 由 Paul G. Richardson, Emily Blood, Constantine S. Mitsiades, Sundar Jagannath, Steven R. Zeldenrust, Melissa Alsina, Robert Schlossman, S. Vincent Rajkumar, K.R. Desikan, Teru Hideshima, Nikhil C. Munshi, Kathleen Kelly-Colson, Deborah Doss, Mary McKenney, Svetlana G. Gorelik, Diane Warren, Andrea Freeman, Rebecca L. Rich, Anfang Wu, Marta Olesnyckyj, Kenton Wride, William S. Dalton, Jerome B. Zeldis, Robert Knight, Edie Weller, Kenneth C. Anderson

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: